Requires Authorization
Transient suppression of high-prevalence Kell blood group antigens and concomitant development of a Kell-related antibody that appears to recognize a high-prevalence Kell antigen not previously defined
, , , , , and
Dec 31, 2024
About this article
Published Online: Dec 31, 2024
Page range: 153 - 158
DOI: https://doi.org/10.2478/immunohematology-2024-021
Keywords
© 2024 Thomas Larsen Titze et al., published by Sciendo
Titze, Thomas Larsen
Department of Immunology and Transfusion Medicine, Oslo University HospitalOslo, Norway
Ulvahaug, Norunn
Transfusion Service, Vestfold HospitalTønsberg, Norway
Moksnes, Magnus
Cancer and Hematology Center, Vestfold HospitalTønsberg, Norway
Skeie, Nanna
Department of Immunology and Transfusion Medicine, Oslo University HospitalOslo, Norway
Crew, Vanja Karamatic
International Blood Group Reference Laboratory, NHS Blood and TransplantBristol, UK
Akkök, Çiğdem Akalın
Department of Immunology and Transfusion Medicine, Oslo University HospitalOslo, Norway
Thornton, Nicole
International Blood Group Reference Laboratory, NHS Blood and TransplantBristol, UK